We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
PTC
PTC
$13.7B
| $301K | ﹤0.01% |
+3,869
| New | +$274K |
|
|
XLRN
1327
DELISTED
Acceleron Pharma
XLRN
| $301K | ﹤0.01% |
3,162
+1,539
| +95% | +$148K |
|
1328
A10 Networks
ATEN
$2.47B
| $300K | ﹤0.01% |
44,090
+29,728
| +207% | +$200K |
|
1329
Quanex
NX
$854M
| $298K | ﹤0.01% |
+21,474
| New | +$256K |
|
1330
Standex International
SXI
$3.68B
| $296K | ﹤0.01% |
+5,138
| New | +$260K |
|
1331
BioNTech
BNTX
$22.6B
| $295K | ﹤0.01% |
+4,426
| New | +$221K |
|
1332
Tennant Co
TNC
$1.5B
| $293K | ﹤0.01% |
4,504
-34,662
| -89% | -$2.11M |
|
|
INN
1333
Summit Hotel Properties
INN
$761M
| $292K | ﹤0.01% |
+49,245
| New | +$278K |
|
|
RDS.A
1334
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $291K | ﹤0.01% |
+8,900
| New | +$305K |
|
|
CLDT
1335
Chatham Lodging
CLDT
$630M
| $289K | ﹤0.01% |
+47,141
| New | +$316K |
|
|
STR
1336
DELISTED
Sitio Royalties
STR
| $289K | ﹤0.01% |
22,567
-6,621
| -23% | -$69.5K |
|
1337
Strategic Education
STRA
$1.71B
| $288K | ﹤0.01% |
+1,873
| New | +$292K |
|
1338
Henry Schein
HSIC
$9.74B
| $286K | ﹤0.01% |
4,890
-128,381
| -96% | -$7.17M |
|
1339
Trustmark
TRMK
$2.73B
| $285K | ﹤0.01% |
+11,615
| New | +$280K |
|
|
NKLA
1340
DELISTED
Nikola Corporation Common Stock
NKLA
| $281K | ﹤0.01% |
+139
| New | +$134K |
|
1341
Vipshop
VIPS
$6.84B
| $280K | ﹤0.01% |
+14,082
| New | +$242K |
|
1342
PagSeguro Digital
PAGS
$2.57B
| $277K | ﹤0.01% |
+7,843
| New | +$221K |
|
1343
Central Pacific Financial
CPF
$997M
| $272K | ﹤0.01% |
16,963
+13,607
| +405% | +$216K |
|
1344
Precigen
PGEN
$1.93B
| $271K | ﹤0.01% |
+54,327
| New | +$185K |
|
|
HSII
1345
DELISTED
Heidrick & Struggles
HSII
| $270K | ﹤0.01% |
+12,498
| New | +$275K |
|
1346
Liberty Global Class A
LBTYA
$3.31B
| $268K | ﹤0.01% |
12,260
+11,818
| +2,674% | +$244K |
|
1347
Virtus Investment Partners
VRTS
$1.11B
| $268K | ﹤0.01% |
2,305
-8,383
| -78% | -$785K |
|
1348
Transmedics
TMDX
$2.5B
| $267K | ﹤0.01% |
+14,898
| New | +$233K |
|
|
VIOT
1349
Viomi Technology
VIOT
$50.5M
| $267K | ﹤0.01% |
50,415
+17,542
| +53% | +$96.2K |
|
1350
Cheniere Energy
LNG
$56.5B
| $266K | ﹤0.01% |
5,500
-81,093
| -94% | -$3.54M |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.